Tags

Commercialisation agreement Arrotex

CStone grants Arrotex exclusive rights to commercialise Sugemalimab in Australia, New Zealand

CStone grants Arrotex exclusive rights to commercialise Sugemalimab in Australia, New Zealand

June 26, 2026 | 09:47
CStone Pharmaceuticals (HKEX: 2616) has signed an exclusive commercialisation agreement with Arrotex, granting rights to its oncology therapy Sugemalimab across the Australia and New Zealand markets.

Latest News

Hong Kong celebrates 50 years of international dragon boat racing on 27-28 June

Hong Kong celebrates 50 years of international dragon boat racing on 27-28 June

SCNet.AI deploys AI and HPC to put scientific research agents within reach

SCNet.AI deploys AI and HPC to put scientific research agents within reach

Fleet Management launches Pulse platform on International Day of the Seafarer

Fleet Management launches Pulse platform on International Day of the Seafarer

Football legend Luis Suarez joins 1win as FIFA World Cup 2026 official ambassador

Football legend Luis Suarez joins 1win as FIFA World Cup 2026 official ambassador

Vietnam Investment Review under the Ministry of Finance

Editor-in-Chief: Pham Van Hoanh

Deputy Editors-in-Chief: Le Trong Minh, Ngo Chi Tung, Nguyen Van Hong

Managing Editor: Nguyen Chi Mai

Advertisement  | Contact us

Based on MasterCMS Ultimate Edition 2026 v2.9
Corporate CEO Talk Biz Link PR Newswire Media OutReach Newswire
Investing M&A Outbound Investment Investing in Haiphong
Your Consultant KPMG PwC Indochine Counsel Vilasia
Green Growth Energy Efficiency Rethinking Plastics BASF
Property Green Buildings Industrial Properties
Money Insurance Smart Payment Trends Stock Monitor
Infographics
Timeout Travel Hotels & Restaurants The Insider Entertainment Lifestyle
Sports
Photos
Society CSR Swing for the Kids
World News
virs-publications-vir
timeout-vn
ptbv2020